Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5137/1019-5149.JTN.44181-23.0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease.
World J Gastroenterol
December 2024
Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto M5G 1X8, Ontario, Canada.
In this article, we comment on the article by Qu and Li, focusing specifically on the non-invasive diagnostic approaches for metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD is the most common chronic liver disease in children. Nearly half of pediatric MASLD cases progress to metabolic dysfunction-associated steatohepatitis at diagnosis, often with comorbidities like renal disease, hypertension, type 2 diabetes, and mental health disorders.
View Article and Find Full Text PDFThe Genus Is at Least as Well Supported as , , and . Comment on Moreyra et al. African Mountain Thistles: Three New Genera in the - Group. 2023, , 3083.
Plants (Basel)
December 2024
Department of Botany and Zoology, Faculty of Science, Masaryk University, Kotlářská 2, 61137 Brno, Czech Republic.
Moreyra and co-authors, in their recent paper published in , presented a desperately needed Hyb-Seq phylogeny of the genus . Through their findings, they provided a critical assessment of an earlier proposal of ours to separate sect. and into the genera and , respectively.
View Article and Find Full Text PDFComment on: A Soaring Price, a Silent Fight: Thioguanine Portends New Access Barriers to Life-Saving Treatments for Children With Cancer: The Ugly Duck or The Chicken with the Golden Eggs: The Crisis in Thioguanine Accessibility.
Pediatr Blood Cancer
February 2025
Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.
SGLT2 inhibitors in the prevention of diabetic cardiomyopathy: Targeting the silent threat.
World J Cardiol
November 2024
Department of 1st Cardiology, Athens Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.
Heart failure (HF) is a major global health challenge, particularly among individuals with type 2 diabetes mellitus (T2DM), who are at significantly higher risk of developing HF. Diabetic cardiomyopathy, a unique form of heart disease, often progresses silently until advanced stages. Recent research has focused on sodium-dependent glucose transporter 2 inhibitors (SGLT2i), originally developed for hyperglycemia, which have shown potential in reducing cardiovascular risks, including HF hospitalizations, irrespective of diabetic status.
View Article and Find Full Text PDFThe silent struggle: anxiety in men with prostate cancer.
JNCI Cancer Spectr
September 2024
Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!